“Bullish on Laurus Labs, recommending a buy with a target price of ₹2,050 and a stop loss of ₹1,870. The stock has shown a range breakout on the daily chart, holding well above it, with buying visible across Pharma stocks supporting the uptrend. The overall setup looks bullish, with declines being bought into.”

Chandan Taparia’s track record: 3 graded calls · 95% CI 0–56%